Cercle, an AI company transforming women’s healthcare data into actionable insights, has raised $6 million in a seed funding round led by Outsiders Fund. Other investors include FemHealth Ventures, CGHealth Ventures, Rogue Women’s Fund, and existing backers like Sheryl Sandberg and Tom Bernthal’s SBVP fund. This new funding will support Cercle’s expansion beyond the fertility market, improve its AI-driven platform, and enhance its large language model (LLM) capabilities.
Cercle’s core offering, the Cercle Biomedical Graph, is designed to process and analyze vast amounts of de-identified healthcare data. This system generates real-time insights that women’s healthcare providers use to improve both clinical outcomes and operational efficiency. The company has already partnered with notable organizations, including US Fertility, Boston IVF, and Eurofins Genoma in Europe, where its platform has been used to improve care for fertility patients by providing more accurate treatment plans and timelines.
The platform’s technology can address a major issue in healthcare—80% of healthcare data is unstructured and difficult to analyze. By transforming this data into structured insights, Cercle enables more efficient operations and helps providers offer more personalized care.
Co-founder and CEO Juan Carlos Riveiro leads the company’s technical efforts to integrate high-quality women’s health data with large language models (LLMs). “Women’s healthcare is under-researched, underfunded, and underserved,” said Ashley Finch, Cercle’s COO. “Our mission at Cercle is simple and clear: to leverage the power of AI to generate insights from women’s health data in order to drive efficiencies for providers, develop drugs faster, and improve care for patients.”
With its platform, Cercle aims to broaden its reach beyond fertility into areas like menopause, women’s oncology, and rare diseases that disproportionately affect women. The company also plans to expand globally, driven by this recent seed funding.
“Cercle is a truly exciting innovator at the intersection of AI and women’s healthcare,” said George Easley, Principal at Outsiders Fund. “Their best-in-class infrastructure, LLM interface, and AI models provide serious leverage to clinicians and healthcare operators alike.”
Dr. Eduardo Hariton, VP of Strategic Initiatives at US Fertility, added, “Cercle’s unique AI platform has meaningfully enhanced both our business operations and clinical workflows. Extracting insights from raw data is labor-intensive and costly. Cercle’s AI platform enables us to do this more efficiently and at scale, leading to both better outcomes for our business and a better experience for our patients.”
